MRNA crashed 24% on a leaked cancer trial leak, dragging Merck lower. NVDA, META, TSLA, IBM, GEV, CAT, GTLB, DELL and …
source
©2026 INVESTORS HEALTH WordPress Video Theme by WPEnjoy
MRNA crashed 24% on a leaked cancer trial leak, dragging Merck lower. NVDA, META, TSLA, IBM, GEV, CAT, GTLB, DELL and …
source